Asia-Pacific Randomization and Trial Supply Management (RTSM) Market is expected to grow with the CAGR of 14.2% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Asia-Pacific randomization and trial supply management (RTSM) market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Asia-Pacific randomization and trial supply management (RTSM) market are introducing strong range of products provider along with receiving large number of CE mark approvals for launching new products into the market.
Oracle is the dominating player in randomization and trial supply management (RTSM) market. The other key players existing in the market includes are Cenduit LLC, ICON plc, Parexel International Corporation, IBM Corporation, 4G Clinical, Ennov, Bioclinica., eClinical Solutions LLC., Statistics & Data Corporation, Baiao known, Zhejiang Taimei Medical Technology Co., Ltd., Medrio, Inc., IDDI., and Medidata Solutions, Inc.(Dassault Systemes) among others.
Oracle was found in 1977 and is headquartered in Texas, United States. The company is engaged in helping people see data in new ways, discover insights and unlock endless possibilities. The company has multiple business segments as cloud and license, hardware and services where cloud and license are the market focused segment. The company has Infrastructures and life science applications where life science applications is the market focused category.
The company also has global presence in Asia Pacific, Europe, and Middle East and Africa, The Americas. The company has subsidiaries like Taleo, Aconex, Textura Corporation, and Agile among others.
Parexel International Corporation
Parexel International Corporation is headquartered in Massachusetts in United States which was founded in 1982. Company is leading in providing of wide range of drug development abilities to the worldwide CROs. The company offers a range of leading software and service categories such as Parexel biotech, clinical development, consulting, outsourcing services, medical aaffairs, real-world evidence and late phase where clinical development is the market focused category.
The company has presence in Asia Pacific, Europe, and Middle East and Africa, The Americas. The subsidiaries are Perceptive Informatics Inc. (U.K.), PAREXEL International (India) Private Limited (India), PAREXEL MMS Europe Limited (U.K.), PAREXEL International (Thailand) Co Ltd (Thailand), and DATALABS INC (U.S.) among others.
Bioclinica is headquartered in New Jersey, U.S. The company is engaged in providing medical science and technology expertise to life science industry, advancing the development of medical therapies for people around world. Company also has wide product portfolio in medical imaging, clinical trial software, specialty solutions, drug safety where clinical trial software is market focused category.
The company has presence in North America, Europe, and Asia-Pacific.